Drugs / PPI-461
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01247194 Comparator | Oct 2010 → May 2011 | chronic hepatitis C virus infection | Presidio Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PPI-461 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01247194 ↗ |
| Route | Oral | “capsule, oral, once daily for 3 days” NCT01247194 ↗ |